Literature DB >> 27614685

Role of angiogenic factors of herbal origin in regulation of molecular pathways that control tumor angiogenesis.

Manoj Kumar1, Sunil Kumar Dhatwalia1, D K Dhawan2.   

Abstract

The formation of blood capillaries to sustain development and growth of new tissues is referred to as angiogenesis. Angiogenesis is pivotal in both carcinogenesis and metastasis since capillaries are the sole source of supplying nutrients and oxygen to the proliferating tumor cells; therefore, this dependency of tumor growth on angiogenesis challenges researchers to halt tumor growth by targeting angiogenesis with the help of either synthetic or natural inhibitors. Many synthetic inhibitors of angiogenesis have not only come into force but also resulted in some severe adverse effects. Natural compounds may effectively fit into this condition and possibly decrease the time of treatment. In the recent past, literature is replete with evidences advocating the usefulness of natural compounds that target multiple biochemical pathways. The additional advantage of natural compounds is that their active principles interact with one another and work synergistically to give more meaningful and reliable effects than individual principle. Hence, if we are somehow able to combine more than two natural compounds, then it may be possible to enhance their potential by many folds, which shall prove to be very effective in combating tumor angiogenesis. This review shall discuss the concept of angiogenesis, molecular pathways, and angiogenic inhibitors and their specific targets and potential of natural compounds to greatly enhance the current knowledge of angiogenesis-inhibiting factors.

Entities:  

Keywords:  Angiogenesis; Natural compounds; Signaling molecules; Tumor

Mesh:

Substances:

Year:  2016        PMID: 27614685     DOI: 10.1007/s13277-016-5330-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  176 in total

1.  Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B.

Authors:  R Mohan; J Sivak; P Ashton; L A Russo; B Q Pham; N Kasahara; M B Raizman; M E Fini
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

Review 2.  Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence.

Authors:  Lauren M Willis; Azza B El-Remessy; Payaningal R Somanath; David L Deremer; Susan C Fagan
Journal:  Clin Sci (Lond)       Date:  2011-04       Impact factor: 6.124

Review 3.  Current development of mTOR inhibitors as anticancer agents.

Authors:  Sandrine Faivre; Guido Kroemer; Eric Raymond
Journal:  Nat Rev Drug Discov       Date:  2006-08       Impact factor: 84.694

4.  Resveratrol inhibits VEGF gene expression and proliferation of hepatocarcinoma cells.

Authors:  Huizhen Zhang; Rui Yang
Journal:  Hepatogastroenterology       Date:  2014 Mar-Apr

5.  Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice.

Authors:  Y Kimura; H Okuda
Journal:  J Nutr       Date:  2001-06       Impact factor: 4.798

6.  Silibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation.

Authors:  Cynthia Tilley; Gagan Deep; Chapla Agarwal; Michael F Wempe; David Biedermann; Kateřina Valentová; Vladimir Kren; Rajesh Agarwal
Journal:  Mol Carcinog       Date:  2014-12-09       Impact factor: 4.784

7.  Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.

Authors:  Sanjeev Banerjee; Carlos Bueso-Ramos; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

Review 8.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

9.  Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.

Authors:  L E Benjamin; D Golijanin; A Itin; D Pode; E Keshet
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  trans-3,4,5'-Trihydroxystibene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells.

Authors:  Zongxian Cao; Jing Fang; Chang Xia; Xianglin Shi; Bing-Hua Jiang
Journal:  Clin Cancer Res       Date:  2004-08-01       Impact factor: 12.531

View more
  8 in total

Review 1.  Co-Targeting Tumor Angiogenesis and Immunosuppressive Tumor Microenvironment: A Perspective in Ethnopharmacology.

Authors:  Jianbo Zhou; Li Wang; Cheng Peng; Fu Peng
Journal:  Front Pharmacol       Date:  2022-06-15       Impact factor: 5.988

2.  Blockade of angiopoietin-2/Tie2 signaling pathway specifically promotes inflammation-induced angiogenesis in mouse cornea.

Authors:  Zhi-Xin Yan; Yi Luo; Ning-Fei Liu
Journal:  Int J Ophthalmol       Date:  2017-08-18       Impact factor: 1.779

Review 3.  Potential applications of artemisinins in ocular diseases.

Authors:  Bing-Wen Lu; Li-Ke Xie
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

Review 4.  Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review.

Authors:  Ahmed M Al-Abd; Abdulmohsin J Alamoudi; Ashraf B Abdel-Naim; Thikryat A Neamatallah; Osama M Ashour
Journal:  J Adv Res       Date:  2017-06-27       Impact factor: 10.479

5.  Antiangiogenic effects of oridonin.

Authors:  Lili Tian; Kangjie Xie; Donglai Sheng; Xiaoqing Wan; Guofu Zhu
Journal:  BMC Complement Altern Med       Date:  2017-04-04       Impact factor: 3.659

Review 6.  Starvation tactics using natural compounds for advanced cancers: pharmacodynamics, clinical efficacy, and predictive biomarkers.

Authors:  Khalid El Bairi; Mariam Amrani; Said Afqir
Journal:  Cancer Med       Date:  2018-05-06       Impact factor: 4.452

7.  Improved Wound Healing by Naringin Associated with MMP and the VEGF Pathway.

Authors:  Jia-Hau Yen; Wan-Ting Chio; Chia-Ju Chuang; Hsin-Ling Yang; Sheng-Teng Huang
Journal:  Molecules       Date:  2022-03-04       Impact factor: 4.411

8.  Preliminary safety assessment of oridonin in zebrafish.

Authors:  Lili Tian; Donglai Sheng; Qiushuang Li; Chenxu Guo; Guofu Zhu
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.